South Texas Accelerated Research Therapeutics (START)
San Antonio, Texas, United States
Oncologist in San Antonio, Texas
4383 Medical Dr # 3046, San Antonio, TX 78229
About South Texas Accelerated Research Therapeutics (START)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Daiichi Sankyo, Inc.
3
Eli Lilly and Company
3
Mersana Therapeutics
3
Birdie Biopharmaceuticals HK Limited
2
Millennium Pharmaceuticals, Inc.
2
Pfizer
2
Aadi Bioscience, Inc.
1
Amgen
1
Array Biopharma, now a wholly owned subsidiary of Pfizer
1
Bristol-Myers Squibb
1
Celgene
1
Clinical Trials at South Texas Accelerated Research Therapeutics (START)
During the past decade, South Texas Accelerated Research Therapeutics (START) conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 6 clinical trials were completed, i.e. on
average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
2007-06-01
2008-06-01
Withdrawn
25
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
2007-09-01
2017-05-22
Completed
184
Dose Escalation Study of EC D-3263 HCl in Advanced Solid Tumors
2009-03-01
2012-04-01
Completed
23
Dose Finding, Safety and Tolerability Study for AC220 to Treat Advanced Solid Tumors
2010-01-01
2011-11-01
Completed
45
Study of Orally Administered TAK-960 in Patients With Advanced Nonhematologic Malignancies
2010-09-01
2013-01-01
Terminated
32
Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors
2010-10-01
2014-03-01
Completed
176
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "South Texas Accelerated Research Therapeutics (START)" #1 sponsor was "Daiichi Sankyo, Inc." with 3 trials, followed by "Eli Lilly and Company" with 3 trials
sponsored, "Mersana Therapeutics" with 3 trials sponsored, "Birdie Biopharmaceuticals HK Limited" with 2 trials sponsored and "Millennium Pharmaceuticals, Inc."
with 2 trials sponsored. Other sponsors include 23 different institutions and
companies that sponsored additional 32 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "South Texas Accelerated Research Therapeutics (START)"
#1 collaborator was "Loxo Oncology, Inc." with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Seven and Eight Biopharmaceuticals Inc" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "IQVIA Biotech" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at South Texas Accelerated Research Therapeutics (START)
According to Clinical.Site data, the most researched conditions in "South Texas Accelerated Research Therapeutics (START)" are
"Solid Tumors" (6 trials), "Advanced Solid Tumors" (5 trials), "Cancer" (4 trials), "Solid Tumor" (4 trials) and "Advanced Cancer" (3 trials). Many other conditions were trialed in "South Texas Accelerated Research Therapeutics (START)" in a lesser frequency.
Clinical Trials Intervention Types at South Texas Accelerated Research Therapeutics (START)
Most popular intervention types in "South Texas Accelerated Research Therapeutics (START)" are "Drug" (40 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Abemaciclib" (3 trials), "Pembrolizumab" (3 trials), "BDB001" (2 trials), "Capecitabine" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.
Clinical Trials Genders at South Texas Accelerated Research Therapeutics (START)
The vast majority of trials in "South Texas Accelerated Research Therapeutics (START)" are
40 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at South Texas Accelerated Research Therapeutics (START)
Currently, there are NaN active trials in "South Texas Accelerated Research Therapeutics (START)".
undefined are not yet recruiting,
11 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in South Texas Accelerated Research Therapeutics (START),
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in South Texas Accelerated Research Therapeutics (START), 39 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".